| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRG2 GABRG3 FLT3 OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 P2RY12 FZD3 HLA-DQB1 LAG3 OR2W1 P2RY13 OR14I1 OR2J2 OPN1SW CHRM5 ADGRG4 GFRA2 OR8U8 OR10D3 PROKR1 OR4P4 ADRB1 IL22RA2 PTPRA GPR174 PROKR2 AGTR2 FZD10 C3AR1 OR8B12 GABRA1 GABRA2 GABRA3 SORL1 OR2A2 | 2.13e-19 | 1353 | 100 | 38 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 P2RY12 FZD3 OR2W1 P2RY13 OR14I1 OR2J2 OPN1SW CHRM5 ADGRG4 OR8U8 OR10D3 PROKR1 OR4P4 ADRB1 GPR174 PROKR2 AGTR2 FZD10 C3AR1 OR8B12 OR2A2 | 1.35e-13 | 884 | 100 | 26 | GO:0004930 |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 1.28e-09 | 11 | 100 | 5 | GO:0008503 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 2.32e-08 | 18 | 100 | 5 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 3.13e-08 | 19 | 100 | 5 | GO:0004890 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 7.01e-08 | 22 | 100 | 5 | GO:0016917 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 9.59e-08 | 75 | 100 | 7 | GO:0098960 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.80e-07 | 50 | 100 | 6 | GO:0099095 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.16e-07 | 125 | 100 | 8 | GO:0015108 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR14I1 OR2J2 OR8U8 OR10D3 OR4P4 OR8B12 OR2A2 | 2.39e-07 | 431 | 100 | 13 | GO:0004984 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 5.45e-07 | 60 | 100 | 6 | GO:0099529 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 6.99e-07 | 100 | 100 | 7 | GO:0030594 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 9.18e-07 | 151 | 100 | 8 | GO:0008509 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.34e-06 | 171 | 100 | 8 | GO:0015103 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.41e-06 | 77 | 100 | 6 | GO:0005230 | |
| GeneOntologyMolecularFunction | chloride channel activity | 4.61e-06 | 86 | 100 | 6 | GO:0005254 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 9.70e-06 | 57 | 100 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.31e-05 | 103 | 100 | 6 | GO:0005253 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.85e-05 | 65 | 100 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.85e-05 | 65 | 100 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | odorant binding | 4.30e-05 | 127 | 100 | 6 | GO:0005549 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 5.30e-05 | 193 | 100 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 6.03e-05 | 197 | 100 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.29e-04 | 24 | 100 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 2.48e-04 | 61 | 100 | 4 | GO:1901682 | |
| GeneOntologyMolecularFunction | ribosomal protein S6 kinase activity | 5.13e-04 | 7 | 100 | 2 | GO:0004711 | |
| GeneOntologyMolecularFunction | transporter activity | GABRG2 GABRG3 SLC11A2 SLC26A4 SLC26A5 CHRM5 SLC7A9 SLC25A40 SLC15A1 PITPNA SLC38A11 TMEM41B KCNT1 GABRA1 GABRA2 GABRA3 | 6.49e-04 | 1289 | 100 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | tripeptide transmembrane transporter activity | 8.74e-04 | 9 | 100 | 2 | GO:0042937 | |
| GeneOntologyMolecularFunction | oxalate transmembrane transporter activity | 1.09e-03 | 10 | 100 | 2 | GO:0019531 | |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 1.33e-03 | 11 | 100 | 2 | GO:0008271 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 1.33e-03 | 11 | 100 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRG2 GABRG3 SLC11A2 SLC26A4 SLC26A5 CHRM5 SLC15A1 KCNT1 GABRA1 GABRA2 GABRA3 | 1.44e-03 | 758 | 100 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | immune receptor activity | 1.45e-03 | 165 | 100 | 5 | GO:0140375 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.46e-03 | 334 | 100 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | G protein-coupled neurotransmitter receptor activity | 1.87e-03 | 13 | 100 | 2 | GO:0099528 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 1.87e-03 | 13 | 100 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 1.87e-03 | 13 | 100 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | G protein-coupled purinergic nucleotide receptor activity | 1.87e-03 | 13 | 100 | 2 | GO:0045028 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRG2 GABRG3 SLC11A2 SLC26A4 SLC26A5 CHRM5 SLC15A1 KCNT1 GABRA1 GABRA2 GABRA3 | 2.06e-03 | 793 | 100 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRG2 GABRG3 SLC11A2 SLC26A4 SLC26A5 CHRM5 SLC7A9 SLC25A40 SLC15A1 SLC38A11 KCNT1 GABRA1 GABRA2 GABRA3 | 2.21e-03 | 1180 | 100 | 14 | GO:0022857 |
| GeneOntologyMolecularFunction | sulfate transmembrane transporter activity | 2.85e-03 | 16 | 100 | 2 | GO:0015116 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 2.85e-03 | 16 | 100 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 3.22e-03 | 17 | 100 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 5.37e-03 | 22 | 100 | 2 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 5.37e-03 | 22 | 100 | 2 | GO:0001614 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 P2RY12 FZD3 OR2W1 P2RY13 OR14I1 OR2J2 OPN1SW CHRM5 ADGRG4 OR8U8 OR10D3 PROKR1 OR4P4 ADRB1 GPR174 PROKR2 AGTR2 PRKCA FZD10 C3AR1 OR8B12 CCL14 SORL1 OR2A2 | 1.02e-11 | 1395 | 100 | 29 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR14I1 OR2J2 OR8U8 OR10D3 OR4P4 OR8B12 OR2A2 | 1.70e-07 | 432 | 100 | 13 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 SLC26A4 SLC26A5 OR2W1 OR14I1 OR2J2 OPN1SW PKHD1L1 OR8U8 CEMIP RNF170 OR10D3 OR4P4 PITPNA OR8B12 OR2A2 | 1.76e-07 | 1072 | 100 | 20 | GO:0007600 |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 3.13e-07 | 30 | 100 | 5 | GO:1904862 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR14I1 OR2J2 OR8U8 OR10D3 OR4P4 OR8B12 OR2A2 | 3.93e-07 | 465 | 100 | 13 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR14I1 OR2J2 OR8U8 OR10D3 OR4P4 OR8B12 OR2A2 | 6.32e-07 | 485 | 100 | 13 | GO:0050907 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 7.00e-07 | 35 | 100 | 5 | GO:0007214 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 7.97e-07 | 153 | 100 | 8 | GO:0098656 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 1.22e-06 | 112 | 100 | 7 | GO:1902476 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR14I1 OR2J2 OR8U8 OR10D3 OR4P4 OR8B12 OR2A2 | 1.50e-06 | 524 | 100 | 13 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR14I1 OR2J2 OR8U8 OR10D3 OR4P4 OR8B12 OR2A2 | 2.41e-06 | 547 | 100 | 13 | GO:0007606 |
| GeneOntologyBiologicalProcess | chloride transport | 2.98e-06 | 128 | 100 | 7 | GO:0006821 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.06e-06 | 183 | 100 | 8 | GO:0006820 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 4.04e-06 | 134 | 100 | 7 | GO:0098661 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR14I1 OR2J2 OR8U8 OR10D3 OR4P4 OR8B12 OR2A2 | 4.73e-06 | 582 | 100 | 13 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR14I1 OR2J2 OPN1SW OR8U8 OR10D3 OR4P4 OR8B12 OR2A2 | 9.98e-06 | 722 | 100 | 14 | GO:0051606 |
| GeneOntologyBiologicalProcess | inorganic anion transport | 2.77e-05 | 180 | 100 | 7 | GO:0015698 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 2.77e-05 | 180 | 100 | 7 | GO:0060078 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 2.99e-05 | 74 | 100 | 5 | GO:0051932 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 2.81e-04 | 65 | 100 | 4 | GO:0072348 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRG2 GABRG3 SLC11A2 P2RY12 SLC26A4 SLC26A5 CEMIP GPD1L ADRB1 SLC15A1 PRKCA KCNT1 GABRA1 GABRA2 GABRA3 | 3.01e-04 | 1115 | 100 | 15 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRG2 GABRG3 SLC11A2 P2RY12 SLC26A4 SLC26A5 CEMIP GPD1L ADRB1 SLC15A1 KCNT1 GABRA1 GABRA2 GABRA3 | 3.88e-04 | 1017 | 100 | 14 | GO:0098660 |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | 4.81e-04 | 7 | 100 | 2 | GO:0106071 | |
| GeneOntologyBiologicalProcess | cellular response to histamine | 4.81e-04 | 7 | 100 | 2 | GO:0071420 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 2.63e-08 | 19 | 101 | 5 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 4.56e-08 | 21 | 101 | 5 | GO:1902710 | |
| GeneOntologyCellularComponent | dendrite membrane | 7.49e-06 | 56 | 101 | 5 | GO:0032590 | |
| GeneOntologyCellularComponent | chloride channel complex | 8.17e-06 | 57 | 101 | 5 | GO:0034707 | |
| GeneOntologyCellularComponent | cell projection membrane | GABRG2 GABRG3 SLC11A2 P2RY12 SLC26A4 SLC7A9 MACF1 GABRA1 GABRA2 GABRA3 | 4.52e-05 | 431 | 101 | 10 | GO:0031253 |
| GeneOntologyCellularComponent | neuron projection membrane | 4.84e-05 | 82 | 101 | 5 | GO:0032589 | |
| GeneOntologyCellularComponent | leading edge membrane | 5.49e-04 | 210 | 101 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.21e-03 | 164 | 101 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | cone photoreceptor outer segment | 1.24e-03 | 11 | 101 | 2 | GO:0120199 | |
| MousePheno | abnormal GABA-mediated receptor currents | 1.87e-06 | 18 | 72 | 4 | MP:0004008 | |
| Domain | GPCR_Rhodpsn_7TM | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 P2RY12 OR2W1 P2RY13 OR14I1 OR2J2 OPN1SW CHRM5 OR8U8 PROKR1 OR4P4 ADRB1 GPR174 PROKR2 AGTR2 C3AR1 OR8B12 OR2A2 | 4.86e-12 | 670 | 99 | 22 | IPR017452 |
| Domain | 7tm_1 | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 P2RY12 OR2W1 P2RY13 OR14I1 OR2J2 OPN1SW CHRM5 OR8U8 PROKR1 OR4P4 ADRB1 GPR174 PROKR2 AGTR2 C3AR1 OR8B12 OR2A2 | 5.96e-12 | 677 | 99 | 22 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 P2RY12 OR2W1 P2RY13 OR14I1 OR2J2 OPN1SW CHRM5 OR8U8 PROKR1 OR4P4 ADRB1 GPR174 PROKR2 AGTR2 C3AR1 OR8B12 OR2A2 | 7.51e-12 | 685 | 99 | 22 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 P2RY12 OR2W1 P2RY13 OR14I1 OR2J2 OPN1SW CHRM5 OR8U8 PROKR1 OR4P4 ADRB1 GPR174 PROKR2 AGTR2 C3AR1 OR8B12 OR2A2 | 8.90e-12 | 691 | 99 | 22 | PS50262 |
| Domain | GPCR_Rhodpsn | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 P2RY12 OR2W1 P2RY13 OR14I1 OR2J2 OPN1SW CHRM5 OR8U8 PROKR1 OR4P4 ADRB1 GPR174 PROKR2 AGTR2 C3AR1 OR8B12 OR2A2 | 9.16e-12 | 692 | 99 | 22 | IPR000276 |
| Domain | GABAA/Glycine_rcpt | 1.18e-07 | 23 | 99 | 5 | IPR006028 | |
| Domain | Olfact_rcpt | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR14I1 OR2J2 OR8U8 OR4P4 OR8B12 OR2A2 | 1.13e-06 | 393 | 99 | 12 | IPR000725 |
| Domain | GABAAa_rcpt | 2.86e-06 | 6 | 99 | 3 | IPR001390 | |
| Domain | Neurotransmitter_ion_chnl_CS | 3.90e-06 | 45 | 99 | 5 | IPR018000 | |
| Domain | Neur_chan_memb | 4.36e-06 | 46 | 99 | 5 | PF02932 | |
| Domain | Neur_chan_LBD | 4.86e-06 | 47 | 99 | 5 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 4.86e-06 | 47 | 99 | 5 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 4.86e-06 | 47 | 99 | 5 | IPR006029 | |
| Domain | - | 4.86e-06 | 47 | 99 | 5 | 2.70.170.10 | |
| Domain | Neur_channel | 4.86e-06 | 47 | 99 | 5 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 4.86e-06 | 47 | 99 | 5 | IPR006202 | |
| Domain | GABBAg_rcpt | 8.32e-05 | 3 | 99 | 2 | IPR005437 | |
| Domain | G8 | 1.66e-04 | 4 | 99 | 2 | PF10162 | |
| Domain | G8_domain | 1.66e-04 | 4 | 99 | 2 | IPR019316 | |
| Domain | G8 | 1.66e-04 | 4 | 99 | 2 | PS51484 | |
| Domain | G8 | 1.66e-04 | 4 | 99 | 2 | SM01225 | |
| Domain | Ribosomal_S6_kinase_II | 4.11e-04 | 6 | 99 | 2 | IPR016239 | |
| Domain | WxxW_domain | 4.11e-04 | 6 | 99 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 4.11e-04 | 6 | 99 | 2 | PF13330 | |
| Domain | S04_transporter_CS | 5.74e-04 | 7 | 99 | 2 | IPR018045 | |
| Domain | Pectin_lyase_fold/virulence | 7.63e-04 | 8 | 99 | 2 | IPR011050 | |
| Domain | NPY_rcpt | 9.77e-04 | 9 | 99 | 2 | IPR000611 | |
| Domain | Pkinase_C | 9.85e-04 | 37 | 99 | 3 | IPR017892 | |
| Domain | SLC26A | 1.22e-03 | 10 | 99 | 2 | PS01130 | |
| Domain | Pkinase_C | 1.43e-03 | 42 | 99 | 3 | PF00433 | |
| Domain | STAS | 1.48e-03 | 11 | 99 | 2 | PS50801 | |
| Domain | STAS_dom | 1.48e-03 | 11 | 99 | 2 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 1.48e-03 | 11 | 99 | 2 | IPR011547 | |
| Domain | Frizzled | 1.48e-03 | 11 | 99 | 2 | IPR000539 | |
| Domain | Frizzled | 1.48e-03 | 11 | 99 | 2 | PF01534 | |
| Domain | STAS | 1.48e-03 | 11 | 99 | 2 | PF01740 | |
| Domain | SLC26A/SulP_fam | 1.48e-03 | 11 | 99 | 2 | IPR001902 | |
| Domain | - | 1.48e-03 | 11 | 99 | 2 | 3.30.750.24 | |
| Domain | Sulfate_transp | 1.48e-03 | 11 | 99 | 2 | PF00916 | |
| Domain | Frizzled | 1.48e-03 | 11 | 99 | 2 | SM01330 | |
| Domain | Myosin_N | 2.79e-03 | 15 | 99 | 2 | PF02736 | |
| Domain | Myosin_N | 2.79e-03 | 15 | 99 | 2 | IPR004009 | |
| Domain | Frizzled/SFRP | 3.18e-03 | 16 | 99 | 2 | IPR015526 | |
| Domain | AGC-kinase_C | 3.27e-03 | 56 | 99 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.27e-03 | 56 | 99 | 3 | PS51285 | |
| Domain | S_TK_X | 3.27e-03 | 56 | 99 | 3 | SM00133 | |
| Domain | GPCR_2_secretin-like | 3.97e-03 | 60 | 99 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 3.97e-03 | 60 | 99 | 3 | IPR017981 | |
| Domain | Myosin_tail_1 | 4.03e-03 | 18 | 99 | 2 | PF01576 | |
| Domain | Myosin_tail | 4.03e-03 | 18 | 99 | 2 | IPR002928 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.16e-03 | 61 | 99 | 3 | PS50261 | |
| Domain | Myosin-like_IQ_dom | 4.48e-03 | 19 | 99 | 2 | IPR027401 | |
| Domain | - | 4.48e-03 | 19 | 99 | 2 | 4.10.270.10 | |
| Domain | FRI | 4.97e-03 | 20 | 99 | 2 | SM00063 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | OR7C2 P2RY12 OR2W1 P2RY13 OR2J2 OPN1SW CHRM5 ADRB1 GPR174 AGTR2 C3AR1 | 2.64e-07 | 260 | 81 | 11 | M39397 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 SLC26A5 OR2W1 OR14I1 OR2J2 OPN1SW OR8U8 OR10D3 OR4P4 PRKCA OR8B12 OR2A2 | 5.32e-07 | 636 | 81 | 16 | M41834 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR14I1 OR2J2 OR8U8 OR10D3 OR4P4 OR8B12 OR2A2 | 6.65e-07 | 417 | 81 | 13 | M4072 |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 8.35e-07 | 31 | 81 | 5 | M39369 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR14I1 OR2J2 OR8U8 OR4P4 OR8B12 OR2A2 | 2.09e-06 | 389 | 81 | 12 | M14091 |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 2.39e-06 | 38 | 81 | 5 | M39854 | |
| Pathway | WP_GPCRS_NONODORANT | P2RY12 FZD3 P2RY13 CHRM5 PROKR1 ADRB1 GPR174 PROKR2 AGTR2 C3AR1 | 2.79e-06 | 266 | 81 | 10 | MM15843 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | GABRG2 GABRG3 P2RY13 CHRM5 ADRB1 AGTR2 C3AR1 GABRA1 GABRA2 GABRA3 | 3.41e-06 | 272 | 81 | 10 | M13380 |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 5.31e-06 | 119 | 81 | 7 | M48309 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.12e-05 | 186 | 81 | 8 | MM15994 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 1.50e-05 | 9 | 81 | 3 | M22034 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.86e-05 | 144 | 81 | 7 | MM14501 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 2.13e-05 | 10 | 81 | 3 | M477 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 2.13e-05 | 10 | 81 | 3 | MM1401 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.26e-05 | 205 | 81 | 8 | M752 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.36e-05 | 60 | 81 | 5 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.36e-05 | 60 | 81 | 5 | M976 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | P2RY12 FZD3 P2RY13 OPN1SW CHRM5 PROKR1 ADRB1 PROKR2 AGTR2 FZD10 C3AR1 | 6.49e-05 | 463 | 81 | 11 | M507 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.12e-04 | 330 | 81 | 9 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.20e-04 | 333 | 81 | 9 | MM14963 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.57e-04 | 270 | 81 | 8 | M15514 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | P2RY12 FZD3 RPS6KA3 P2RY13 OPN1SW CHRM5 PROKR1 ADRB1 PROKR2 AGTR2 PRKCA FZD10 C3AR1 | 1.69e-04 | 702 | 81 | 13 | M746 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.07e-04 | 211 | 81 | 7 | MM14502 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 2.85e-04 | 101 | 81 | 5 | M39387 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 3.22e-04 | 5 | 81 | 2 | MM15108 | |
| Pathway | WP_WNT_SIGNALING | 4.12e-04 | 61 | 81 | 4 | MM15893 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING | 4.82e-04 | 6 | 81 | 2 | M47936 | |
| Pathway | WP_PRIMARY_OVARIAN_INSUFFICIENCY | 4.90e-04 | 174 | 81 | 6 | M48058 | |
| Pathway | WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS | 5.56e-04 | 66 | 81 | 4 | M39642 | |
| Pathway | REACTOME_RSK_ACTIVATION | 6.72e-04 | 7 | 81 | 2 | M27369 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 7.85e-04 | 430 | 81 | 9 | MM15160 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 8.93e-04 | 8 | 81 | 2 | M47642 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY | 8.93e-04 | 8 | 81 | 2 | M47814 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 1.14e-03 | 36 | 81 | 3 | M39908 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 1.14e-03 | 9 | 81 | 2 | M47641 | |
| Pathway | BIOCARTA_SRCRPTP_PATHWAY | 1.42e-03 | 10 | 81 | 2 | MM1341 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 1.73e-03 | 11 | 81 | 2 | MM15049 | |
| Pathway | BIOCARTA_SRCRPTP_PATHWAY | 1.73e-03 | 11 | 81 | 2 | M10994 | |
| Pubmed | 6.70e-11 | 4 | 101 | 4 | 26518133 | ||
| Pubmed | 6.70e-11 | 4 | 101 | 4 | 25080596 | ||
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 1.00e-09 | 6 | 101 | 4 | 15033447 | |
| Pubmed | 1.55e-09 | 18 | 101 | 5 | 19078961 | ||
| Pubmed | 1.55e-09 | 18 | 101 | 5 | 18985723 | ||
| Pubmed | 4.65e-09 | 8 | 101 | 4 | 8175718 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR2J2 OR10D3 OR4P4 OR8B12 OR2A2 | 4.82e-09 | 340 | 101 | 11 | 11875048 |
| Pubmed | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR2J2 OR10D3 OR4P4 OR8B12 OR2A2 | 4.82e-09 | 340 | 101 | 11 | 11802173 | |
| Pubmed | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR2J2 OR10D3 OR4P4 OR8B12 OR2A2 | 5.28e-09 | 343 | 101 | 11 | 32295537 | |
| Pubmed | OR5M10 OR8U1 OR8B4 OR7C2 OR4S2 OR2W1 OR2J2 OR10D3 OR4P4 OR8B12 OR2A2 | 5.77e-09 | 346 | 101 | 11 | 14611657 | |
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 1.39e-08 | 10 | 101 | 4 | 21789198 | |
| Pubmed | 1.39e-08 | 10 | 101 | 4 | 20583128 | ||
| Pubmed | 2.18e-08 | 11 | 101 | 4 | 39137998 | ||
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 2.18e-08 | 11 | 101 | 4 | 38894703 | |
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 15017002 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 16835366 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 15304513 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 29023704 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 1356407 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 14715953 | ||
| Pubmed | Association study between GABA receptor genes and anxiety spectrum disorders. | 9.49e-08 | 4 | 101 | 3 | 19842164 | |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 25865415 | ||
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 9.49e-08 | 4 | 101 | 3 | 18821008 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 28978485 | ||
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 2.37e-07 | 5 | 101 | 3 | 30104684 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 12574411 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 27129275 | ||
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 9682826 | ||
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 20457185 | ||
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 21751815 | ||
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 7560270 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 8.25e-07 | 7 | 101 | 3 | 20843900 | |
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 35228700 | ||
| Pubmed | theta, a novel gamma-aminobutyric acid type A receptor subunit. | 8.25e-07 | 7 | 101 | 3 | 10449790 | |
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 16101898 | ||
| Pubmed | 1.32e-06 | 8 | 101 | 3 | 11528422 | ||
| Pubmed | 1.84e-06 | 197 | 101 | 7 | 36604605 | ||
| Pubmed | 2.81e-06 | 10 | 101 | 3 | 36733270 | ||
| Pubmed | 2.82e-06 | 300 | 101 | 8 | 19086053 | ||
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 3.71e-06 | 219 | 101 | 7 | 12213199 | |
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 3.86e-06 | 11 | 101 | 3 | 9924185 | |
| Pubmed | 4.02e-06 | 81 | 101 | 5 | 22723691 | ||
| Pubmed | Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease. | 5.13e-06 | 12 | 101 | 3 | 2561974 | |
| Pubmed | 6.66e-06 | 13 | 101 | 3 | 22569571 | ||
| Pubmed | 6.66e-06 | 13 | 101 | 3 | 22640814 | ||
| Pubmed | Postsynaptic clustering of gamma-aminobutyric acid type A receptors by the gamma3 subunit in vivo. | 8.35e-06 | 2 | 101 | 2 | 10536013 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22763624 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15610161 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16901473 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 28800362 | ||
| Pubmed | Involvement of c-Jun N-terminal kinases activation in diabetic embryopathy. | 8.35e-06 | 2 | 101 | 2 | 17449011 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 11886876 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23147414 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23109109 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22509377 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22666188 | ||
| Pubmed | The extracellular loop of pendrin and prestin modulates their voltage-sensing property. | 8.35e-06 | 2 | 101 | 2 | 29777056 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 8391122 | ||
| Pubmed | Impaired maturation of cortical GABA(A) receptor expression in pediatric epilepsy. | 8.35e-06 | 2 | 101 | 2 | 20132297 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18973555 | ||
| Pubmed | Diazepam Accelerates GABAAR Synaptic Exchange and Alters Intracellular Trafficking. | 8.35e-06 | 2 | 101 | 2 | 31080408 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22132188 | ||
| Pubmed | Reversal of pathological pain through specific spinal GABAA receptor subtypes. | 8.35e-06 | 2 | 101 | 2 | 18202657 | |
| Pubmed | Role of the P2Y12 receptor in the modulation of murine dendritic cell function by ADP. | 8.35e-06 | 2 | 101 | 2 | 20952684 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23687280 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 9655866 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23457547 | ||
| Pubmed | Mutation screen of GABRA1, GABRB2 and GABRG2 genes in Japanese patients with absence seizures. | 8.35e-06 | 2 | 101 | 2 | 15955415 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 30423260 | ||
| Pubmed | Novel α1 and γ2 GABAA receptor subunit mutations in families with idiopathic generalized epilepsy. | 8.35e-06 | 2 | 101 | 2 | 21714819 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16412095 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 14766194 | ||
| Pubmed | Molecular and neuronal substrate for the selective attenuation of anxiety. | 8.35e-06 | 2 | 101 | 2 | 11021797 | |
| Pubmed | Gender-specific contribution of the GABA(A) subunit genes on 5q33 in methamphetamine use disorder. | 8.35e-06 | 2 | 101 | 2 | 14569258 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18085262 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20940303 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 24553732 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21073549 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23744069 | ||
| Pubmed | Functional mapping of GABA A receptor subtypes in the amygdala. | 8.35e-06 | 2 | 101 | 2 | 15341600 | |
| Pubmed | Functional Studies of Deafness-Associated Pendrin and Prestin Variants. | 8.35e-06 | 2 | 101 | 2 | 38474007 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21056629 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26984842 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20356767 | ||
| Pubmed | Epilepsy plus blindness in microdeletion of GABRA1 and GABRG2 in mouse and human. | 8.35e-06 | 2 | 101 | 2 | 37703949 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 35150350 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23067879 | ||
| Pubmed | Enrichment of GABAA Receptor α-Subunits on the Axonal Initial Segment Shows Regional Differences. | 8.35e-06 | 2 | 101 | 2 | 26973458 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16843602 | ||
| Pubmed | 8.45e-06 | 14 | 101 | 3 | 22768092 | ||
| Pubmed | 1.30e-05 | 16 | 101 | 3 | 24305805 | ||
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 1.59e-05 | 182 | 101 | 6 | 20468064 | |
| Pubmed | Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain. | 1.88e-05 | 18 | 101 | 3 | 31910261 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19667192 | ||
| Pubmed | Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin. | 2.50e-05 | 3 | 101 | 2 | 21921024 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 27128218 | ||
| Pubmed | Identification of the sites for CaMK-II-dependent phosphorylation of GABA(A) receptors. | 2.50e-05 | 3 | 101 | 2 | 17442679 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 10813773 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 32540960 | ||
| Pubmed | Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse. | 2.50e-05 | 3 | 101 | 2 | 21729720 | |
| Interaction | GABRG2 interactions | 1.77e-05 | 34 | 93 | 4 | int:GABRG2 | |
| Interaction | OR8U1 interactions | 2.11e-05 | 2 | 93 | 2 | int:OR8U1 | |
| Cytoband | 11q24.2 | 1.19e-05 | 63 | 101 | 4 | 11q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 6.78e-05 | 191 | 101 | 5 | chr11q24 | |
| Cytoband | Xq26.3 | 4.47e-04 | 67 | 101 | 3 | Xq26.3 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.55e-08 | 19 | 79 | 5 | 563 | |
| GeneFamily | Prokineticin receptors | 1.89e-05 | 2 | 79 | 2 | 216 | |
| GeneFamily | Olfactory receptors, family 8 | 6.16e-05 | 49 | 79 | 4 | 155 | |
| GeneFamily | Purinergic receptors P2Y | 8.29e-04 | 10 | 79 | 2 | 213 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 1.01e-03 | 11 | 79 | 2 | 1156 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 1.01e-03 | 11 | 79 | 2 | 286 | |
| GeneFamily | Solute carriers | 1.69e-03 | 395 | 79 | 7 | 752 | |
| GeneFamily | Myosin heavy chains | 1.91e-03 | 15 | 79 | 2 | 1098 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8-.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 2.75e-05 | 85 | 88 | 5 | GSM605843_100 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 2.91e-05 | 86 | 88 | 5 | GSM605840_100 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.SLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-3 | 3.08e-05 | 87 | 88 | 5 | GSM854299_100 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.MLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-2 | 3.08e-05 | 87 | 88 | 5 | GSM854297_100 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-06 | 168 | 100 | 6 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-06 | 168 | 100 | 6 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 169 | 100 | 6 | 454b92b9b67299a64278c010db033ca5b9d217a0 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 169 | 100 | 6 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 180 | 100 | 6 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 180 | 100 | 6 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 181 | 100 | 6 | fb64da1dde37fe6ba7de2586cd58848ac1974f24 | |
| ToppCell | LAM-Myeloid-DC|LAM / Condition, Lineage and Cell class | 4.23e-06 | 188 | 100 | 6 | b4140110c2f7d25fd8a0d2749e33e02003ac4bf2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.49e-06 | 190 | 100 | 6 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.22e-06 | 195 | 100 | 6 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 5.53e-06 | 197 | 100 | 6 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.79e-05 | 143 | 100 | 5 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.32e-05 | 151 | 100 | 5 | 0b6b37734430918378ed94e40877f0c4ae9b25ec | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-05 | 151 | 100 | 5 | 30225a1a7800b0ae19e16ac164f561379eedb99d | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.74e-05 | 77 | 100 | 4 | a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 157 | 100 | 5 | 7fdc0094dd5729990a91a30c1982a14c74650b52 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 157 | 100 | 5 | c762b03e254c73222094725ca8ac1c8eb428bccb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 157 | 100 | 5 | 6b5b08bb5520fcf6f4c0560f7ed7645ec179806d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 160 | 100 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 160 | 100 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.76e-05 | 167 | 100 | 5 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.76e-05 | 167 | 100 | 5 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 169 | 100 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Immune_cells-Dendritic_cells|World / Lineage and Cell class | 4.09e-05 | 170 | 100 | 5 | 094dc211d80c89ecb1010855f1fe6eeb71bf0e20 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 171 | 100 | 5 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 171 | 100 | 5 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 172 | 100 | 5 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.57e-05 | 174 | 100 | 5 | b6e3fa995def40a8fbdfc249fe108c303931a171 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-05 | 176 | 100 | 5 | d4075796c38b775fe721abb47426e662a0d415e3 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-05 | 178 | 100 | 5 | 742ee0cb8cb585a5e34bd5b20aebe9bb99756e0c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 179 | 100 | 5 | 7ae67e1c09a4ce9b3bcec4c48ee9cf2b1cb4e339 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 180 | 100 | 5 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 180 | 100 | 5 | df60970520fba2ac0639faa54096766d07418ca4 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 180 | 100 | 5 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 180 | 100 | 5 | 0b653b1b653b40f3b8711d1312029a4a8a4961db | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-05 | 180 | 100 | 5 | 6b1606238417490e0d9930870a7827419d1c3737 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 181 | 100 | 5 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 181 | 100 | 5 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | Immune_cells-Dendritic_cells|Immune_cells / Lineage and Cell class | 5.66e-05 | 182 | 100 | 5 | 99c7d4f1e7cd745643ba64b59190113bcd4e348e | |
| ToppCell | Control-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 5.80e-05 | 183 | 100 | 5 | bdd461349a1ef43a015843937d26e8d3571ecc22 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue | 6.11e-05 | 185 | 100 | 5 | f78be85dd6e443abb7af20f98ff351c1131ece4d | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.59e-05 | 188 | 100 | 5 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-05 | 188 | 100 | 5 | 0d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.59e-05 | 188 | 100 | 5 | 9fc3819aae5a2b2534cb131d467435b5cfc420d6 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.59e-05 | 188 | 100 | 5 | 5e5d779ea079d3b2a1ef650b06b9f5cc1ffef5e7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.76e-05 | 189 | 100 | 5 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 190 | 100 | 5 | 078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285 | |
| ToppCell | COVID-19-Myeloid-DC2|COVID-19 / Condition, Lineage and Cell class | 7.11e-05 | 191 | 100 | 5 | 1304ab7b5713f29f3966ffc020ea1b52e8e2f375 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 191 | 100 | 5 | 4187f31ec399b4c7c3608e94e3c32b7a54b1c3d4 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 191 | 100 | 5 | 8e8bc200524a44ebe132f823ab7c15dac65d4952 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-05 | 192 | 100 | 5 | 90274b85f3d612b6a6d435860cd6d049ddeb1d96 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-05 | 193 | 100 | 5 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-05 | 193 | 100 | 5 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-05 | 193 | 100 | 5 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.46e-05 | 193 | 100 | 5 | 48ce11778252ae2ef902b30816061b59a3c81695 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-05 | 193 | 100 | 5 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-05 | 195 | 100 | 5 | 9cfbdb528088ad0ab100c7431c7d8f140a846de8 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.83e-05 | 195 | 100 | 5 | 7bb3bdfb8caaae357b1f7841d8d00936c4373dfe | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-05 | 195 | 100 | 5 | 66f3b3e15eaa21bc7cf2f204cac81de1a160a748 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.83e-05 | 195 | 100 | 5 | b6bf75669f267ecdc96818c7022db852e37a9fe1 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-05 | 195 | 100 | 5 | bbf5f79be4fcea754328f1af7ee5625075248100 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.83e-05 | 195 | 100 | 5 | d579150d176e6bd81004b5146de4901ca13a3c3e | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-DC2|lymph-node_spleen / Manually curated celltypes from each tissue | 8.03e-05 | 196 | 100 | 5 | 9666b5380e2b2a3c3b56a8c769817a1df8820ed6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.22e-05 | 197 | 100 | 5 | 50f994e0d4e69019ec92e164edf3e4e951333766 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.22e-05 | 197 | 100 | 5 | a357ee2ba9100dfaeba9ecae8138a2776bb54b0b | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.22e-05 | 197 | 100 | 5 | 555ea43eccc3eb22be230c27e13d8b3b64c2a61f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.42e-05 | 198 | 100 | 5 | 979c391a3b7130e4f91d76a9eb8079fb0f445c4c | |
| ToppCell | background-Kupffer_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.62e-05 | 199 | 100 | 5 | 91d229f3515d49639bcb5505e6aec4a9abade81c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.62e-05 | 199 | 100 | 5 | c684530d4d8073337379c2a24e5e54297fb13691 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.62e-05 | 199 | 100 | 5 | 18b6087863fda22e3e2a2167e7daeb347df1d95b | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.83e-05 | 200 | 100 | 5 | 390f9429feae991b8524e2815d8fcd4914c74459 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 200 | 100 | 5 | f0e7c2f07a7065511bf0b6521ce2e74e04e48544 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 200 | 100 | 5 | 1adebb306112bfc4926678de80f70d35dd57a586 | |
| ToppCell | mLN-Dendritic_cell-cDC2|Dendritic_cell / Region, Cell class and subclass | 8.83e-05 | 200 | 100 | 5 | e3f7852aaa26a9b3e626d85e40afde799e873045 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.83e-05 | 200 | 100 | 5 | f7e9b4a8ededb116774528b38ea3381b6f05915c | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.83e-05 | 200 | 100 | 5 | d98c523ac0e4767aaeef50cae142513d115212ab | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.Dapl1_(Dapl1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.59e-05 | 106 | 100 | 4 | 7079111add27d7b3411dfe739280d62dc256a174 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.Dapl1_(Dapl1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.59e-05 | 106 | 100 | 4 | a6334b67be05f78145b57271b7959471b80bd67f | |
| ToppCell | Thalamus-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 113 | 100 | 4 | f606c2003ce9b17f3c27a7c24ee6bf30f28a2b06 | |
| ToppCell | Thalamus-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 113 | 100 | 4 | 9b239bfa00aa2d2e27d13d80fe54ef4f2fea49c0 | |
| ToppCell | Thalamus-Hematopoietic-MICROGLIA|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 113 | 100 | 4 | b82c5dd560a0e309f2b79ca874b006f914baade7 | |
| ToppCell | Thalamus-Hematopoietic-MICROGLIA-MI2(C1qb)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 113 | 100 | 4 | d5e6f36d2d6afaadfbf60b56c16ed15775139ed4 | |
| ToppCell | Thalamus-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 113 | 100 | 4 | a339ddee70054612afef3cc9dc156738202af4cd | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 117 | 100 | 4 | 240cd636d1f5d3f270825ace02126fae993f5802 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.45e-04 | 118 | 100 | 4 | 3cebd17f4688cd43fe1283dc60957e87d5536810 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.45e-04 | 118 | 100 | 4 | 61b00b001edb1954a5fffaf4dfe71708124a45e5 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.45e-04 | 118 | 100 | 4 | 71f63efc641cd07c870f7695118fb244929c1536 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.93e-04 | 127 | 100 | 4 | 0750743574c2fca8df07e11d73e8b94579209609 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-04 | 128 | 100 | 4 | cfc73cb803ba50a4a8709e19e70e1e399118c849 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.36e-04 | 134 | 100 | 4 | 0e3f37ef041b751ed45060b5ce39385a2731370b | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.87e-04 | 141 | 100 | 4 | a32947b13e888850c979a54c137512e4b96d2f36 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.87e-04 | 141 | 100 | 4 | 2cb651d63466fdcce011d1dd8de409ef439d03e7 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tfh|Lung / Manually curated celltypes from each tissue | 2.95e-04 | 142 | 100 | 4 | 319812c84fad93276bf093f2ad78db02ae745bf4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-04 | 145 | 100 | 4 | bfa196ac1db7acbfcbb2ba9f137036a95e16e091 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-04 | 145 | 100 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-04 | 147 | 100 | 4 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-04 | 147 | 100 | 4 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6.Tcf4_(Supramammillary_Nucleus_(SuM))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.49e-04 | 61 | 100 | 3 | 46cdf693c7f2df4fc43df7837b152871af67bef0 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6.Tcf4_(Supramammillary_Nucleus_(SuM))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.49e-04 | 61 | 100 | 3 | c73fa489427a6e11badbdfc0324008137806ac7d | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6.Tcf4_(Supramammillary_Nucleus_(SuM))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.49e-04 | 61 | 100 | 3 | c2c633f49f6ad8581c33794c909f40aa59f0b5c5 | |
| Computational | Genes in the cancer module 396. | 2.41e-05 | 12 | 53 | 3 | MODULE_396 | |
| Computational | Genes in the cancer module 141. | 6.06e-05 | 16 | 53 | 3 | MODULE_141 | |
| Computational | Ion channels. | 3.05e-04 | 27 | 53 | 3 | MODULE_214 | |
| Drug | Lorazepam | 1.75e-09 | 5 | 100 | 4 | ctd:D008140 | |
| Drug | metaclazepam | 1.85e-09 | 13 | 100 | 5 | CID000071272 | |
| Drug | dihydroxyaflavinine | 8.77e-09 | 17 | 100 | 5 | CID000156857 | |
| Drug | 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane | 2.42e-08 | 8 | 100 | 4 | ctd:C091518 | |
| Drug | 6 mEq | 3.67e-08 | 22 | 100 | 5 | CID000126186 | |
| Drug | tiotidine | 4.34e-08 | 9 | 100 | 4 | ctd:C023990 | |
| Drug | methohexital | 5.88e-08 | 24 | 100 | 5 | CID000009034 | |
| Drug | thiamylal | 7.40e-08 | 49 | 100 | 6 | CID003032285 | |
| Drug | Zolpidem | 8.22e-08 | 3 | 100 | 3 | DB00425 | |
| Drug | fosazepam | 1.13e-07 | 11 | 100 | 4 | CID000037114 | |
| Drug | C19H18ClN3O | 1.13e-07 | 11 | 100 | 4 | CID000027452 | |
| Drug | flutoprazepam | 1.13e-07 | 11 | 100 | 4 | CID000003400 | |
| Drug | Arfendazam | 1.13e-07 | 11 | 100 | 4 | CID000065803 | |
| Drug | camazepam | 1.13e-07 | 11 | 100 | 4 | CID000037367 | |
| Drug | triflubazam | 1.13e-07 | 11 | 100 | 4 | CID000031157 | |
| Drug | Bu-1014 | 1.13e-07 | 11 | 100 | 4 | CID015942721 | |
| Drug | Zapizolam | 1.13e-07 | 11 | 100 | 4 | CID000068832 | |
| Drug | Reclazepam | 1.13e-07 | 11 | 100 | 4 | CID003052777 | |
| Drug | iclazepam | 1.13e-07 | 11 | 100 | 4 | CID000068777 | |
| Drug | menitrazepam | 1.13e-07 | 11 | 100 | 4 | CID000189875 | |
| Drug | Serin hydrazid | 1.13e-07 | 11 | 100 | 4 | CID000041637 | |
| Drug | sulazepam | 1.13e-07 | 11 | 100 | 4 | CID000017931 | |
| Drug | elfazepam | 1.13e-07 | 11 | 100 | 4 | CID000065445 | |
| Drug | uldazepam | 1.13e-07 | 11 | 100 | 4 | CID000034274 | |
| Drug | gidazepam | 1.13e-07 | 11 | 100 | 4 | CID000121919 | |
| Drug | fletazepam | 1.13e-07 | 11 | 100 | 4 | CID000036834 | |
| Drug | SB-205384 | 1.69e-07 | 12 | 100 | 4 | CID000197690 | |
| Drug | U-93631 | 1.69e-07 | 12 | 100 | 4 | CID000197626 | |
| Drug | haloxazolam | 1.69e-07 | 12 | 100 | 4 | CID000003563 | |
| Drug | pivoxazepam | 1.69e-07 | 12 | 100 | 4 | CID000068722 | |
| Drug | doxefazepam | 1.69e-07 | 12 | 100 | 4 | CID000038668 | |
| Drug | razobazam | 1.69e-07 | 12 | 100 | 4 | CID000071228 | |
| Drug | 3-isothujone | 1.93e-07 | 30 | 100 | 5 | CID000011027 | |
| Drug | SKF89976A | 2.29e-07 | 31 | 100 | 5 | CID000092409 | |
| Drug | AC1MVFYM | 2.43e-07 | 13 | 100 | 4 | CID003707225 | |
| Drug | nerisopam | 2.43e-07 | 13 | 100 | 4 | CID000065875 | |
| Drug | Ro 11-3128 | 2.43e-07 | 13 | 100 | 4 | CID000093364 | |
| Drug | cinolazepam | 2.43e-07 | 13 | 100 | 4 | CID003033621 | |
| Drug | flutazolam | 2.43e-07 | 13 | 100 | 4 | CID000003398 | |
| Drug | alpha IMGBL | 2.43e-07 | 13 | 100 | 4 | CID000131516 | |
| Drug | 4-PIOL | 2.43e-07 | 13 | 100 | 4 | CID000125520 | |
| Drug | CGS 8216 | 3.18e-07 | 33 | 100 | 5 | CID000104916 | |
| Drug | AC1L2FYN | 3.18e-07 | 33 | 100 | 5 | CID000071333 | |
| Drug | tert-butylbicyclo-2-benzoate | 3.28e-07 | 4 | 100 | 3 | ctd:C046308 | |
| Drug | Flumazenil | 3.28e-07 | 4 | 100 | 3 | DB01205 | |
| Drug | etizolam | 3.28e-07 | 4 | 100 | 3 | ctd:C044610 | |
| Drug | beta-CCt | 3.39e-07 | 14 | 100 | 4 | CID000124514 | |
| Drug | Me-lex | 3.39e-07 | 14 | 100 | 4 | CID000004177 | |
| Drug | ethyl loflazepate | 3.39e-07 | 14 | 100 | 4 | CID000003299 | |
| Drug | dehydroepiandrosterone sulfate | GABRG2 GABRG3 ACSL6 P2RY12 P2RY13 FANCA MAPK9 GABRA1 GABRA2 GABRA3 | 3.99e-07 | 277 | 100 | 10 | CID000005244 |
| Drug | flurazepam | 4.32e-07 | 35 | 100 | 5 | CID000003393 | |
| Drug | SR 95103 | 4.61e-07 | 15 | 100 | 4 | CID000125958 | |
| Drug | loprazolam | 4.61e-07 | 15 | 100 | 4 | CID003033860 | |
| Drug | premazepam | 4.61e-07 | 15 | 100 | 4 | CID000072104 | |
| Drug | pinazepam | 4.61e-07 | 15 | 100 | 4 | CID000040391 | |
| Drug | fludiazepam | 4.61e-07 | 15 | 100 | 4 | CID000003369 | |
| Drug | TBOB | 4.61e-07 | 15 | 100 | 4 | CID000114986 | |
| Drug | girisopam | 4.61e-07 | 15 | 100 | 4 | CID000071257 | |
| Drug | trans-4-aminocrotonic acid | 4.96e-07 | 67 | 100 | 6 | CID000002766 | |
| Drug | secobarbital | 5.76e-07 | 37 | 100 | 5 | CID000005193 | |
| Drug | tetrazepam | 6.12e-07 | 16 | 100 | 4 | CID000025215 | |
| Drug | Ro 19-4603 | 6.12e-07 | 16 | 100 | 4 | CID000127382 | |
| Drug | P858 | 6.12e-07 | 16 | 100 | 4 | CID000004617 | |
| Drug | nimetazepam | 6.12e-07 | 16 | 100 | 4 | CID000004496 | |
| Drug | DMCM | 6.61e-07 | 38 | 100 | 5 | CID000104999 | |
| Drug | zaleplon | 7.56e-07 | 39 | 100 | 5 | CID000005719 | |
| Drug | CL 218,872 | 7.98e-07 | 17 | 100 | 4 | CID000107950 | |
| Drug | Eszopiclone | 8.17e-07 | 5 | 100 | 3 | DB00402 | |
| Drug | Zopiclone | 8.17e-07 | 5 | 100 | 3 | DB01198 | |
| Drug | tert-butylbicyclophosphorothionate | 8.17e-07 | 5 | 100 | 3 | ctd:C037476 | |
| Drug | alphaxalone | 8.17e-07 | 5 | 100 | 3 | ctd:C006477 | |
| Drug | Gabrene | 8.61e-07 | 40 | 100 | 5 | CID005361323 | |
| Drug | gaboxadol | 9.77e-07 | 41 | 100 | 5 | CID000003448 | |
| Drug | abecarnil | 1.02e-06 | 18 | 100 | 4 | CID000065914 | |
| Drug | cloxazolam | 1.02e-06 | 18 | 100 | 4 | CID000002816 | |
| Drug | clorazepate | 1.02e-06 | 18 | 100 | 4 | CID000002809 | |
| Drug | lormetazepam | 1.02e-06 | 18 | 100 | 4 | CID000013314 | |
| Drug | phenazepam | 1.02e-06 | 18 | 100 | 4 | CID000040113 | |
| Drug | 5 beta-alphaxalone | 1.10e-06 | 42 | 100 | 5 | CID000068930 | |
| Drug | zolpidem | 1.25e-06 | 43 | 100 | 5 | CID000005732 | |
| Drug | ZK 93426 | 1.29e-06 | 19 | 100 | 4 | CID000115210 | |
| Drug | etifoxine | 1.29e-06 | 19 | 100 | 4 | CID000030768 | |
| Drug | lorazepam | 1.40e-06 | 44 | 100 | 5 | CID000003958 | |
| Drug | AC1N65YL | 1.61e-06 | 20 | 100 | 4 | CID004229818 | |
| Drug | Ro 15-4513 | 1.61e-06 | 20 | 100 | 4 | CID000005081 | |
| Drug | EBOB | 1.61e-06 | 20 | 100 | 4 | CID000115223 | |
| Drug | halazepam | 1.61e-06 | 20 | 100 | 4 | CID000031640 | |
| Drug | Meprobamate | 1.63e-06 | 6 | 100 | 3 | DB00371 | |
| Drug | heptachlor epoxide | 1.76e-06 | 46 | 100 | 5 | CID000013930 | |
| Drug | thymol | 1.76e-06 | 46 | 100 | 5 | CID000006989 | |
| Drug | AC1L1B1W | 1.90e-06 | 84 | 100 | 6 | CID000001248 | |
| Drug | prazepam | 1.98e-06 | 21 | 100 | 4 | CID000004890 | |
| Drug | Flunitrazepam | 1.98e-06 | 21 | 100 | 4 | ctd:D005445 | |
| Drug | bicuculline methochloride | 1.98e-06 | 21 | 100 | 4 | CID000123659 | |
| Drug | R 5135 | 1.98e-06 | 21 | 100 | 4 | CID000119544 | |
| Drug | NSC364150 | 2.18e-06 | 48 | 100 | 5 | CID000100771 | |
| Drug | neostigmine | 2.34e-06 | 87 | 100 | 6 | CID000004456 | |
| Drug | Iomazenil (123I | 2.41e-06 | 22 | 100 | 4 | CID000065959 | |
| Drug | quazepam | 2.41e-06 | 22 | 100 | 4 | CID000004999 | |
| Drug | imidazenil | 2.41e-06 | 22 | 100 | 4 | CID000119194 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 9.62e-06 | 13 | 97 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | X-24736 measurement | 3.20e-05 | 3 | 97 | 2 | EFO_0800904 | |
| Disease | Microcytic anemia | 3.20e-05 | 3 | 97 | 2 | cv:C5194182 | |
| Disease | Coffin-Lowry syndrome (implicated_via_orthology) | 6.39e-05 | 4 | 97 | 2 | DOID:3783 (implicated_via_orthology) | |
| Disease | Iron deficiency anemia | 6.39e-05 | 4 | 97 | 2 | C0162316 | |
| Disease | EPILEPSY, CHILDHOOD ABSENCE, 1 | 1.59e-04 | 6 | 97 | 2 | C1838604 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.73e-04 | 84 | 97 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | response to statin, low density lipoprotein cholesterol measurement | 2.96e-04 | 8 | 97 | 2 | EFO_0004611, GO_0036273 | |
| Disease | hearing impairment | 3.13e-04 | 98 | 97 | 4 | C1384666 | |
| Disease | renovascular hypertension (implicated_via_orthology) | 3.79e-04 | 9 | 97 | 2 | DOID:1591 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 4.73e-04 | 10 | 97 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 4.73e-04 | 10 | 97 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 4.73e-04 | 10 | 97 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 4.73e-04 | 10 | 97 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 4.73e-04 | 10 | 97 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 4.73e-04 | 10 | 97 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 4.73e-04 | 10 | 97 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 4.73e-04 | 10 | 97 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | interleukin-22 receptor subunit alpha-2 measurement | 5.77e-04 | 11 | 97 | 2 | EFO_0020500 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 6.40e-04 | 51 | 97 | 3 | cv:CN043650 | |
| Disease | distal myopathy (implicated_via_orthology) | 6.91e-04 | 12 | 97 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 6.91e-04 | 12 | 97 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 8.15e-04 | 13 | 97 | 2 | C0751122 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 8.15e-04 | 13 | 97 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 8.15e-04 | 13 | 97 | 2 | C0751198 | |
| Disease | Hepatic Encephalopathy | 8.15e-04 | 13 | 97 | 2 | C0019151 | |
| Disease | Hepatic Coma | 8.15e-04 | 13 | 97 | 2 | C0019147 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.09e-03 | 15 | 97 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.09e-03 | 15 | 97 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | cystic fibrosis (is_marker_for) | 1.13e-03 | 62 | 97 | 3 | DOID:1485 (is_marker_for) | |
| Disease | Alcohol abuse | 1.42e-03 | 67 | 97 | 3 | C0085762 | |
| Disease | exercise test | 1.96e-03 | 20 | 97 | 2 | EFO_0004328 | |
| Disease | Amphetamine-Related Disorders | 1.96e-03 | 75 | 97 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 1.96e-03 | 75 | 97 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 1.96e-03 | 75 | 97 | 3 | C0236804 | |
| Disease | Nonsyndromic genetic hearing loss | 2.03e-03 | 76 | 97 | 3 | cv:C5680182 | |
| Disease | urinary bladder cancer (is_implicated_in) | 2.03e-03 | 76 | 97 | 3 | DOID:11054 (is_implicated_in) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.36e-03 | 80 | 97 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.78e-03 | 291 | 97 | 5 | EFO_0008317, EFO_0020946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MPYVCQVCHYRSSVF | 401 | Q86YH2 | |
| VSFYVPLCIMAFVYL | 231 | P08588 | |
| RVFSCYVYQMICDTG | 496 | Q5H9S7 | |
| QEMATISYVPYSCVC | 2316 | Q8IZF6 | |
| TCMSVDRYQSVIYPF | 136 | P50052 | |
| FVMCIPVFVYREIFT | 151 | Q16581 | |
| YSMYQAEEFQVLPCR | 446 | Q8WUJ3 | |
| VVMRSSDCPYIVQFY | 151 | P45985 | |
| YTFRGNCTYVLMREI | 5091 | Q9HC84 | |
| VPFETSCRYMTVLFY | 351 | Q9NXG6 | |
| CISLVTVPYMYGFLN | 141 | Q6IEU7 | |
| YPYCRTVITNEYMKE | 91 | Q00169 | |
| TTLTCVNLFVMPYNY | 376 | Q5JSJ4 | |
| CYVLVSMAYDRYVAI | 111 | Q96RC9 | |
| CIQLVAVPYSYSFLM | 141 | P0C7N1 | |
| ACTNFMMTPYVVTRY | 176 | P45984 | |
| MVCPDYQRYFNTIED | 131 | Q6A162 | |
| AVYQICYESRPVQEM | 326 | Q8N335 | |
| YSFCGTVEYMAPEVV | 226 | P51812 | |
| IQSQDTMPFCYRMYF | 2451 | Q2LD37 | |
| QDYYVVILCPTEMDV | 381 | Q5JUK3 | |
| CYLPRSSIPNYTYVM | 221 | Q7Z465 | |
| GYFVIQTYLPCIMTV | 251 | P47869 | |
| MIYTYSGLFCVTVNP | 116 | P13535 | |
| CADTVYYYQMVPRLT | 621 | Q63HM2 | |
| SMYFILTVAEVCGYR | 321 | Q9Y468 | |
| TISYVGCIIQLYVYM | 91 | Q9Y3N9 | |
| FILTGMAYDRYVAIC | 111 | Q8NGL7 | |
| FILTVMAYDRYVAIC | 111 | Q8NH73 | |
| CYVPQRSIYDTMRIN | 31 | O94854 | |
| VPVSYFIRNMEESYV | 96 | Q0VAA2 | |
| IICSINMYFVVVYVR | 486 | P49281 | |
| GYFVIQTYLPCIMTV | 276 | P34903 | |
| GYFVIQTYLPCIMTV | 251 | P14867 | |
| SYCVVAEIYQPMLDR | 236 | Q969J5 | |
| CILTYRDGFNVSIMY | 241 | P18627 | |
| YSFCGTVEYMAPEVV | 231 | Q9UK32 | |
| CFTYTTYKIPRQRIM | 36 | Q16627 | |
| NMYASIYFLVCISVR | 101 | Q9BXC1 | |
| LVVMSYDRYVAVCRP | 116 | O76002 | |
| VCQVTSVIFYFTMYI | 96 | Q9H244 | |
| LLFVVIMYQYVSPSC | 16 | Q8IZP7 | |
| VYRDYIMSFGLCPVS | 156 | Q86VF5 | |
| RYVAICHPFQYTVIM | 121 | Q6IF42 | |
| CRFSSVIFYETMYVG | 116 | Q9BPV8 | |
| VATYTEGMYPSICVE | 101 | Q8NHR9 | |
| RYVAICNPLLYTVTM | 121 | Q8NGG6 | |
| PFYATEEIYIIMQSC | 911 | P36888 | |
| RPIIFLSMCYCVYSV | 261 | Q9ULW2 | |
| MCYFTNGTERVRYVT | 46 | P01920 | |
| VVVLCIVMDRPYQFY | 501 | Q96PB1 | |
| VPSEYTYRMLFCSCQ | 211 | O00451 | |
| RRMGYFTIQTYIPCI | 251 | Q99928 | |
| VTVMEASIFRRPYYV | 566 | O15360 | |
| PLVTACYILMNVSYF | 261 | P82251 | |
| ISIFSYPELMCEQYV | 71 | Q5K131 | |
| VDAFRMVTASRYYPQ | 101 | Q3B7J2 | |
| RMGYFTIQTYIPCTL | 271 | P18507 | |
| PSPDYMVTARTECYI | 1926 | P08519 | |
| NYVMQYVTVPLRKCT | 251 | Q8IWC1 | |
| RPIIFYAVCYMMVSL | 236 | Q9NPG1 | |
| YASPATVSRCGMVYV | 2236 | Q8IVF4 | |
| VIFAIMARFYTYINP | 661 | P46059 | |
| FCYGVTVILTYPMEC | 246 | Q08AI6 | |
| CSLEPVTVAMAYVYF | 376 | Q9BTV7 | |
| RPHMVQTLEQYEFCY | 771 | P18433 | |
| TVMAYDRFTAICYPL | 116 | Q8NH80 | |
| TMTAYDRFVAICYPL | 116 | O60412 | |
| AFLTVMSYDRYVAIC | 111 | A6ND48 | |
| VVVMVGSFCVCYVPY | 251 | P03999 | |
| YSVTSPQPCEMQRTY | 201 | Q9UPX6 | |
| CIQLVAVPYSYSFLM | 141 | Q8NH10 | |
| MPSASCVYNVYYRVV | 1581 | Q92673 | |
| AIMCRVYVGSIYYEL | 126 | Q9UHX1 | |
| LVMAVPATVIYFTCY | 111 | Q8TBP6 | |
| CFQTVDRLYFVMEYV | 406 | P17252 | |
| SFYPVIMYCFLGTSR | 116 | P58743 | |
| MIYTYSGLFCVTINP | 131 | Q9Y2K3 | |
| ATRQQFYTDMYCPIC | 76 | Q96K19 | |
| YYKISVVLMCFVVPT | 191 | Q86SK9 | |
| YRIVYVTPEYCSGNM | 636 | Q14191 | |
| VIVGNRVYMPCLYVY | 231 | P55039 | |
| AFYIPVSVMTILYCR | 201 | P08912 | |
| ACYTYSMVVVPLYDT | 166 | Q9UKU0 | |
| AIYDTMQYILNPICT | 131 | Q16740 | |
| VAIVCCPFEMDYYVV | 111 | Q8TCW9 | |
| IRFVYTPAMESVCGY | 81 | P01033 | |
| MSEFVCNLSARPYVY | 851 | Q13107 | |
| MNIVSYSFLEIVCVY | 191 | Q9Y548 | |
| YSCSYMVSRPVYSEL | 16 | O43511 | |
| CHVVSLFTQYMPYTL | 451 | Q8N2H3 | |
| DPVVAYYCRLYAMQT | 31 | Q9NP79 | |
| CSVPRCLMYEIYVET | 36 | Q6ZV50 | |
| CCPFEMDYYVVRQLS | 106 | Q8NFJ6 | |
| TQITCYTRAMPEDSY | 96 | Q86WI1 | |
| CVYITPMEALAEQVY | 1376 | O75643 | |
| SFCYMLSYLVGRPVV | 161 | Q5BJD5 | |
| YSVYMGRCVPQESRS | 776 | Q8IWB9 | |
| SYPVMGFEFQVRVCD | 331 | Q8IWB7 | |
| IYPVGYCSTRIYASM | 211 | Q3YBR2 | |
| LVAIVETIMPADYYC | 736 | Q9BYX2 | |
| DLCSEVYRYQVTPRM | 731 | Q8IU80 |